Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER2-negative Breast Cancer|HER2-positive Breast Cancer|Recurrent Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: paclitaxel|BIOLOGICAL: trastuzumab|PROCEDURE: quality-of-life assessment|OTHER: laboratory biomarker analysis
Sponsor: National Cancer Institute (NCI)